Immunogenicity and protective efficacy of a tuberculosis DNA vaccine-Reference-Cited by-同舟云学术

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

Published:1996-08 Issue:8 Volume:2 Page:893-898
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Huygen Kris,Content Jean,Denis Olivier,Montgomery Donna L.,Yawman Anne M.,Randall Deck R.,DeWitt Corrille M.,Orme Ian M.,Baldwin Susan,D'Souza Celine,Drowart Annie,Lozes Evelyne,Vandenbussche Paul,Van Vooren Jean-Paul,Liu Margaret A.,Ulmer Jeffrey B.

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm0896-893.pdf

Reference30 articles.

1. Donnelly, J.J., Ulmer, J.B. & Liu, M.A. Immunization with DNA. J. Immunol. Methods 176, 145–152 (1994).

2. Ulmer, J.B. et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745–1749 (1993).

3. Andersen, P. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect. Immun. 62, 2536–2544 (1994).

4. Wiker, H.G. & Harboe, M. The antigen 85 complex: A major secretion product of Mycobacterium tuberculosis . Microbiol. Rev. 56, 648–661 (1992).

5. Launois, P. et al. T cell epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy. Infect. Immun. 62, 3679–3687 (1994).

Cited by 579 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The 60-year evolution of lipid nanoparticles for nucleic acid delivery;Nature Reviews Drug Discovery;2024-07-04

2. Application of CRISPR–cas-based technology for the identification of tuberculosis, drug discovery and vaccine development;Molecular Biology Reports;2024-03-29

3. It is all in the delivery;Advanced Vaccination Technologies for Infectious and Chronic Diseases;2024

4. Antibodies as clinical tools for tuberculosis;Frontiers in Immunology;2023-12-14

5. Key advances in vaccine development for tuberculosis—success and challenges;npj Vaccines;2023-10-13